Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2073 ARTÍCULOS , VIENDO DEL 1261 AL 1275

Omega-3 fatty acids intake and risks of dementia and Alzheimer's disease: a meta-analysis

Wu S, Ding Y, Wu F, Li R, Hou J, Mao P.

Neurosci Biobehav Rev. 2015 Jan;48:1-9. doi: 10.1016/j.neubiorev.2014.11.008. Epub 2014 Nov 21.

Major depressive disorder and type II diabetes mellitus: mechanisms underlying risk for Alzheimer's disease

Cha DS, Carvalho AF, Rosenblat JD, Ali MM, McIntyre RS.

CNS Neurol Disord Drug Targets. 2014;13(10):1740-9. doi: 10.2174/1871527313666141130204535.

The MTHFR C677T polymorphism contributes to increased risk of Alzheimer's disease: evidence based on 40 case-control studies

Peng Q, Lao X, Huang X, Qin X, Li S, Zeng Z.

Neurosci Lett. 2015 Jan 23;586:36-42. doi: 10.1016/j.neulet.2014.11.049. Epub 2014 Dec 5.

Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis

Agarwal R, Tripathi CB.

Am J Alzheimers Dis Other Demen. 2014 Nov;29(7):575-82. doi: 10.1177/1533317514531443.

Re: Urinary incontinence in patients with Alzheimer's disease: relationship between symptom status and urodynamic diagnoses

Griebling TL.

J Urol. 2015 Mar;193(3):946-7. doi: 10.1016/j.juro.2014.12.071. Epub 2014 Dec 18.

German adaptation of the Resources for Enhancing Alzheimer's Caregiver Health II: study protocol of a single-centred, randomised controlled trial

Heinrich S, Berwig M, Simon A, Jänichen J, Hallensleben N, Nickel W, Hinz A, Brähler E, Gertz HJ.

BMC Geriatr. 2014 Feb 12;14:21. doi: 10.1186/1471-2318-14-21.

New York can be our nation's center for Alzheimer's research

Vann AS.

Am J Alzheimers Dis Other Demen. 2014 Sep;29(6):489-91. doi: 10.1177/1533317514523670. Epub 2014 Feb 18.

Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan

Nakamura Y, Kitamura S, Homma A, Shiosakai K, Matsui D.

Expert Opin Pharmacother. 2014 May;15(7):913-25. doi: 10.1517/14656566.2014.902446. Epub 2014 Mar 27.

Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and Alzheimer's disease

Carman AJ, Dacks PA, Lane RF, Shineman DW, Fillit HM.

J Nutr Health Aging. 2014 Apr;18(4):383-92. doi: 10.1007/s12603-014-0021-7.

Benefit-finding intervention for Alzheimer caregivers: conceptual framework, implementation issues, and preliminary efficacy

Cheng ST, Lau RW, Mak EP, Ng NS, Lam LC.

Gerontologist. 2014 Dec;54(6):1049-58. doi: 10.1093/geront/gnu018. Epub 2014 Mar 31.

The Effectiveness of a Culturally Sensitive Cognitive Behavioral Group Intervention for Latino Alzheimer's Caregivers

Gonyea JG, López LM, Velásquez EH.

Gerontologist. 2016 Apr;56(2):292-302. doi: 10.1093/geront/gnu045. Epub 2014 May 22.

Creation of the Argentina-Alzheimer's Disease Neuroimaging Initiative

Russo MJ, Gustafson D, Vázquez S, Surace E, Guinjoan S, Allegri RF, Sevlever G; Argentina-Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2014 Feb;10(1 Suppl):S84-7. doi: 10.1016/j.jalz.2013.09.015.

[Vitamin D and Alzheimer's disease: from an intriguing idea to a therapeutic option]

Annweiler C.

Biol Aujourdhui. 2014;208(1):89-95. doi: 10.1051/jbio/2014005. Epub 2014 Jun 23.

The UP-TECH project, an intervention to support caregivers of Alzheimer's disease patients in Italy: preliminary findings on recruitment and caregiving burden in the baseline population

Chiatti C, Rimland JM, Bonfranceschi F, Masera F, Bustacchini S, Cassetta L; Fabrizia Lattanzio; UP-TECH research group.

Aging Ment Health. 2015;19(6):517-25. doi: 10.1080/13607863.2014.954526. Epub 2014 Sep 4.

Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease

Wattmo C, Londos E, Minthon L.

BMC Neurol. 2014 Sep 10;14:173. doi: 10.1186/s12883-014-0173-4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias